Presentation is loading. Please wait.

Presentation is loading. Please wait.

European Commercial Potential for Inhalation Drug Delivery in Diabetes Interactive Analyst Briefing - 8 November 2002 Morten Soegaard, Research Analyst.

Published byReginald Simpson Modified over 8 years ago

Similar presentations

Presentation on theme: "European Commercial Potential for Inhalation Drug Delivery in Diabetes Interactive Analyst Briefing - 8 November 2002 Morten Soegaard, Research Analyst."— Presentation transcript:

1 European Commercial Potential for Inhalation Drug Delivery in Diabetes Interactive Analyst Briefing - 8 November 2002 Morten Soegaard, Research Analyst Pharmaceuticals Group

2 European Commercial Potential for Inhalation Drug Delivery in Diabetes Aim and purpose of the report Overview of technologies in development Drivers and restraints for inhalation insulin Strategic challenges Revenue forecasts Conclusions Agenda

3 European Commercial Potential for Inhalation Drug Delivery in Diabetes Aim of the report Methodology Segmentation Insulin Oral diabetes medications Inhalation insulin About the research

4 European Commercial Potential for Inhalation Drug Delivery in Diabetes ExuberaAventis/Pfizer/InhaleLate 2004 AerodoseAerogen2007 TechnospheresPDC2008 AERx iDMSNovo Nordisk/AradigmEarly 2006 AIREli Lilly/Alkermes2008 Technology LaunchCompany Technologies in Development

5 European Commercial Potential for Inhalation Drug Delivery in Diabetes Unmet need for non-invasive insulin delivery Increased use of insulin in type 2 diabetes Price of treatment Concerns over safety Emerging non-invasive delivery technologies Other emerging treatments for diabetes Drivers for Inhalation Insulin Restraints for Inhalation Insulin Drivers and Restraints

6 European Commercial Potential for Inhalation Drug Delivery in Diabetes Time to market Pricing / Reimbursement Device advantage Relative competitiveness Profitability Future Competitive Environment

7 European Commercial Potential for Inhalation Drug Delivery in Diabetes Identifying a medical need More than a convenience technology Expanding the patient base Wider reimbursement Private market Strategic Challenges

8 European Commercial Potential for Inhalation Drug Delivery in Diabetes Launch: mid 2005 $m Benelux Region: Revenue Forecasts

9 European Commercial Potential for Inhalation Drug Delivery in Diabetes Technologies only marginally different Strong focus on marketing effort Notable insulin market share, but from few patients Conclusions

10 European Commercial Potential for Inhalation Drug Delivery in Diabetes For more information contact us on: Tel: +44 (0) 20 7343 8383 Email: enquiries@frost.com www.pharma.frost.com Any Questions?

Download ppt "European Commercial Potential for Inhalation Drug Delivery in Diabetes Interactive Analyst Briefing - 8 November 2002 Morten Soegaard, Research Analyst."

Similar presentations

The European Contrast Media Market, 2002 Interactive Analyst Briefing Sumit Sharma London, UK 27 th Sept, 2002.

The European Contrast Media Market, 2002 Interactive Analyst Briefing Sumit Sharma London, UK 27 th Sept, 2002.
Global Anti Counterfeit Packaging market for Food and Pharmaceuticals- Technologies & Global Markets (2009 to 2014) Markets & Markets – Analyst Briefing.

Global Anti Counterfeit Packaging market for Food and Pharmaceuticals- Technologies & Global Markets (2009 to 2014) Markets & Markets – Analyst Briefing.
European Biomass Power Plant Markets Increased Growth Across Europe Interactive Analyst Briefing Ian French - 21st August 2002.

European Biomass Power Plant Markets Increased Growth Across Europe Interactive Analyst Briefing Ian French - 21st August 2002.
U.S. Bone Growth and Spinal Fusion Stimulator Markets Rapid Growth in Stimulator Market in Recent Years Driven by Quest for Less-invasive Treatment Options.

U.S. Bone Growth and Spinal Fusion Stimulator Markets Rapid Growth in Stimulator Market in Recent Years Driven by Quest for Less-invasive Treatment Options.
China Magnetic Separator Industry Research Report 2015 Published By QYResearch Contact US: Web: www.qyresearchreports.comwww.qyresearchreports.com Blog:

China Magnetic Separator Industry Research Report 2015 Published By QYResearch Contact US: Web: Blog:
Global Sand Washing Machine Industry Research Report 2015 Published By QYResearch Contact US: Web: www.qyresearchreports.comwww.qyresearchreports.com Blog:

Global Sand Washing Machine Industry Research Report 2015 Published By QYResearch Contact US: Web: Blog:
Global Metal Expansion Joints Industry Research Report 2015 Published By QYResearch Contact US: Web: www.qyresearchreports.comwww.qyresearchreports.com.

Global Metal Expansion Joints Industry Research Report 2015 Published By QYResearch Contact US: Web:
Strategic Analysis of the U.S. Infusion Pumps Market

Strategic Analysis of the U.S. Infusion Pumps Market
The European Intravenous Therapy Devices Market “The continuing trend towards alternative care sites increases the demand for smaller, smarter and portable.

The European Intravenous Therapy Devices Market “The continuing trend towards alternative care sites increases the demand for smaller, smarter and portable.
U.S. Diabetes Glucose Self-Monitoring Devices Markets Test Strip Margins and Revenues Decide Profitability in 'Free Meter' Market “The growth in self-monitoring.

U.S. Diabetes Glucose Self-Monitoring Devices Markets Test Strip Margins and Revenues Decide Profitability in 'Free Meter' Market “The growth in self-monitoring.
The European Disposable Surgical Drapes, Gowns & Masks Market

The European Disposable Surgical Drapes, Gowns & Masks Market
Outsourcing Opportunities in the European Industrial Water Sector “This is currently the most exciting and dynamic market in the whole of the European.

Outsourcing Opportunities in the European Industrial Water Sector “This is currently the most exciting and dynamic market in the whole of the European.
U.S. Diabetes Therapies and Complications Markets “The growing demand and the introduction of technologically advanced products is likely to transform.

U.S. Diabetes Therapies and Complications Markets “The growing demand and the introduction of technologically advanced products is likely to transform.
U.S. Neurostimulation Markets Leveraging CRM Technology for Treating Neurological Conditions “Until recently, the only modes of treatment for many neurological.

U.S. Neurostimulation Markets Leveraging CRM Technology for Treating Neurological Conditions “Until recently, the only modes of treatment for many neurological.
The Asian Desalination Plant Market Matthew Barker 10th July 2002 London Office Interactive Analyst Briefing.

The Asian Desalination Plant Market Matthew Barker 10th July 2002 London Office Interactive Analyst Briefing.
The European Blood Banking Devices and Plasma Products Market Tanya Pullen Analyst Briefing 4th December 2002 London Office.

The European Blood Banking Devices and Plasma Products Market Tanya Pullen Analyst Briefing 4th December 2002 London Office.
European IP VPN Services Market Niamh Spillane Research Analyst ‘Growth in this market will be at a less revolutionary pace than predicted in earlier.

European IP VPN Services Market Niamh Spillane Research Analyst ‘Growth in this market will be at a less revolutionary pace than predicted in earlier.
U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth “The tremendous success of bronchodilator/-corticosteroid combination.

U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth “The tremendous success of bronchodilator/-corticosteroid combination.
The European Disposable Airway Management Devices Market Kate Lawrence, Industry Analyst (Surgical Patient Management) The market for disposable airway.

The European Disposable Airway Management Devices Market Kate Lawrence, Industry Analyst (Surgical Patient Management) "The market for disposable airway.
U.S. Blood Banking Industry Food and Drug Administration (FDA) Regulations Limit Donor Pool, Multiply Costs In an effort to curtail the spread of mad.

U.S. Blood Banking Industry Food and Drug Administration (FDA) Regulations Limit Donor Pool, Multiply Costs "In an effort to curtail the spread of mad.

Similar presentations

Ads by Google